LDS/Medical Tests/Lyme Disease (Borrelia burgdorferi) Confirmatory Testing

Lyme Disease (Borrelia burgdorferi) Confirmatory Testing

This test is a proprietary test provided by some laboratories and includes Borrelia Blood Culture and molecular diagnostic testing for B. burgdorferi for diagnosis and management of Lyme disease.

Lyme disease, caused by Borrelia burgdorferi, is an infectious disease transmitted by the ticks Ixodes dammini, I. pacificus, and I. scapularis in the northeastern, midwestern, western, and southeastern United States, respectively. It is the most common vector-borne disease in the United States. Clinical manifestations include a circular rash known as erythema migrans, which appears between two days and two weeks after the initial tick bite. Lyme disease is a multi-system disease. It can affect the heart, nervous system, skin, and joints. Early in the course, clinical identification of erythema migrans is helpful.

The most common screening test for Lyme is serology testing that detects IgM and IgG antibody to B. Burgdorferi. IgM antibodies are detected within 2–6 weeks after the onset of rash, whereas IgG antibodies are detectable sometimes within 6–10 weeks after the onset of disease. IgG antibody may persist for months or years after infection. The test is less sensitive in patients with only a rash. Positive serology results should be confirmed by Lyme disease western blot or by a molecular method (e.g., B. Burgdorferi by PCR) or culture.

Since infection with B. Burgdorferi often is manifested by mild symptoms not specific for Lyme disease, patients may harbor an infection for months to years which in turn can result in chronic long term disorders such as chronic fatigue syndrome or fibromyalgia. At this late stage, Lyme disease will require more specific and complex methodologies for diagnosis and management such as culture and molecular assays.

The Borrelia culture is used as a confirmatory test for infection with B. Burgdorferi (Lyme disease). Culture is a direct test and if positive, indicates that an active infection was present at the time the specimen was taken.

Two different panels; Basic and Advanced

In the basic panel, the blood sample is cultured and the positives are identified by histology and growth characteristics. These are confirmed by fluorescent immunostaining.

The advanced panel will include the basic panel and also PCR using well characterized and published DNA primer sets, and then all positive PCRs will be confirmed by DNA sequencing.

This test will detect all known strains of Borrelia Burgdorferi and is very specific for this organism.

  • Diagnosis and management of B. Burgdorferi infection
  • Diagnosis and management of Lyme disease
  • As an aid in evaluation of chronic fatigue syndrome
  • As an aid in evaluation of chronic fibromyalgia 
Positive results indicate infection with *B. Burgdorferi* (Lyme disease).

Negative (Not Detected). 

 Western blot, Immunoblot.

Serum (SST) or plasma (EDTA).

Stability

  • Ambient: 3-5 days
  • Refrigerated: 5-7 days
  • Frozen: 30 days
DNA sequencing, Lyme by Western Blot and/or PCR, RPR and/or Treponemal antibodies to rule out cross reaction with Syphilis, Babesiosis Serology, Ehrlichiosis serology, Rheumatoid factor, Chronic fatigue syndrome diagnostic panel.
2-5 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Clin Microbiol Rev. 2005 Jul;18(3):484-509. [PMID: 16020686]
  • Med Clin North Am. 2002;86:311. [PMID: 11982304]
  • Vector Borne Zoonotic Dis. 2002 Winter;2(4):223-31. [PMID: 12804163]
  • Clin Infect Dis. 2006;43:1089. [PMID: 17029130]
  • N Engl J Med. 2006;354:2794. [PMID: 16807416]
  • Stevens CD. Clinical Immunology & Serology: A Laboratory Perspective, 3rd edition. Philadelphia: F.A. Davis Company; 2010.